Search


 
Results 1 - 10 of about 46 for "FDA update".

FDA approves new treatment for diabetic foot ulcers | ACP ...

The approval is an expanded indication for the device, which covers the ulcer and allows skin and tissue to regenerate and heal the wound.

Safety alert and advice on CT scanning in patients with insulin ...

The presence of an insulin pump should not preclude an appropriate and medically indicated CT scan, the FDA said.

Follow-on insulin lispro approved | ACP Diabetes Monthly

The injection is approved to improve glucose control in patients ages three years and older with type 1 diabetes and in adult patients with type 2 diabetes ...

Ertugliflozin approved as adjunct treatment for type 2 diabetes ...

As an adjunct to diet and exercise, the drug was approved as monotherapy and for use in fixed-dose combinations with metformin or sitagliptin.

Rosiglitazone REMS ends, new insulin approved | ACP ...

The FDA has determined that the Risk Evaluation and Mitigation Strategy is no longer necessary to ensure that the benefits of rosiglitazone-containing ...

New drugs approved for diabetes | ACP Diabetes Monthly

The first generic version of pioglitazone hydrochloride (Actos) and a new indication for ranibizumab injection (Lucentis) were recently announced by ...

Glucose monitoring app, weight-loss device, medications ...

The FDA approved an app for continuous glucose monitoring, a weight-loss device, a combination diabetes pill, and a new indication for an eye medication ...

Canagliflozin will receive new boxed warning about ...

Canagliflozin (Invokana, Invokamet) increases patients' risk of leg and foot amputations, according to new data from two clinical trials, the FDA recently ...

Empagliflozin approved to treat type 2 diabetes | ACP ...

Empagliflozin (Jardiance), a sodium glucose co-transporter 2 inhibitor, was recently approved to treat type 2 diabetes in addition to diet and exercise ...

Saxagliptin under analysis for heart failure risk | ACP Diabetes ...

The FDA has requested clinical trial data on saxagliptin (Onglyza and Kombiglyze XR) to investigate a possible increase in heart failure in patients ...

Result Page: 1 2 3 4 5  Next >